11 min read
Monthly FDA Guidance and Regulatory News Review - June 2026
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
Meet Veristat at the EMSO 2017 Congress, the most influential annual meeting for oncology professionals in Europe. This year's theme "Integrating science into oncology for a better patient outcome" echos the call across the industry to develop more targeted therapies to extend and improve the lives off cancer patients.
Our teams’ have the expertise and experiences to help you design, build, and run your oncology/hematology clinical development program. And, we’ll help you navigate the regulatory submission process.
Fill out the form on the right hand side of this page to schedule a time to meet with Veristat at ESMO. Even if you are not attending ESMO and want to speak with one of Veristat's experts, fill out the form.
Learn how Veristat helped a current client achieve their patient enrollment timeline for an early phase oncology clinical trial.
11 min read
Jul 7, 2026 Veristat Blog
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
2 min read
Jul 2, 2026 Veristat Blog
June 22, 2026
What the FDA's prior knowledge guidance means for natural history evidence and shared datasets
On June 2,...